Reclassification and risk stratification of embolic stroke of undetermined source by ASCOD phenotyping

被引:1
|
作者
Hoshino, Takao [1 ]
Mizuno, Takafumi [1 ]
Nishimura, Ayako [1 ]
Ishizuka, Kentaro [1 ]
Toi, Sono [1 ]
Takahashi, Shuntaro [1 ]
Wako, Sho [1 ]
Kitagawa, Kazuo [1 ]
机构
[1] Tokyo Womens Med Univ Hosp, Dept Neurol, Tokyo, Japan
关键词
ASCOD; atherosclerosis; cardioembolism; embolic stroke of undetermined source; etiology; small vessel disease; ISCHEMIC-STROKE; ATHEROSCLEROSIS; WARFARIN; ASPIRIN;
D O I
10.1177/17474930221096953
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Common vascular diseases underlying stroke, including atherosclerosis, small-vessel disease (SVD), and cardioembolic pathology, can be present in patients with embolic stroke of undetermined source (ESUS), although these are not direct causes of stroke. Aims: To describe the frequency and degree of the three major diseases using atherosclerosis, SVD, cardiac pathology, other causes, and dissection (ASCOD) phenotyping and to assess their prognostic implications in ESUS. Methods: In this prospective observational study, 221 patients with ESUS within 1 week of onset were consecutively enrolled and followed up for 1 year. Vascular diseases associated with stroke were assessed using the ASCOD classification. The primary outcome was a composite of nonfatal stroke, nonfatal acute coronary syndrome, and vascular death. Results: Among 221 patients (mean age, 69.6 years; male, 59.7%), 135 (61.1%), 102 (46.2%), and 107 (48.4%) had any grade of atherosclerosis (A2 or A3), SVD (S3), and cardiac pathology (C2 or C3), respectively. ESUS patients graded as A2 or A3 (i.e. ipsilateral atherosclerotic plaque, contralateral > 50% stenosis, or aortic arch plaque) were at a significantly higher risk of composite vascular events than those graded as A0 (i.e. no atherosclerotic disease) (adjusted hazard ratio (95% confidence interval), 2.40 (1.01-5.72). No differences were observed in the event risk between patients with S3 (i.e. magnetic resonance imaging evidence of SVD) and S0 (i.e. no SVD) and between those with C2 or C3 (i.e. presence of any cardiac pathology) and C0 (i.e. no cardiac abnormalities). Conclusions: Atherosclerotic diseases corresponding to ASCOD grade A2 or A3 were predictive of recurrent vascular events in ESUS patients. Reclassification of ESUS using ASCOD phenotyping provides important clues for risk prediction and may guide optimal management strategies.
引用
收藏
页码:322 / 330
页数:9
相关论文
共 50 条
  • [31] Anticoagulation and Risk of Stroke Recurrence in Patients with Embolic Stroke of Undetermined Source Having No Potential Source of Embolism
    Sato, Noriko
    Matsuo, Ryu
    Kiyuna, Fumi
    Nakamura, Kuniyuki
    Hata, Jun
    Wakisaka, Yoshinobu
    Ago, Tetsuro
    Kamouchi, Masahiro
    Kitazono, Takanari
    CEREBROVASCULAR DISEASES, 2020, 49 (06) : 601 - 608
  • [32] Embolic strokes of undetermined source in a cohort of Polish stroke patients
    Jan Pawel Bembenek
    Michal Adam Karlinski
    Iwona Kurkowska-Jastrzebska
    Anna Czlonkowska
    Neurological Sciences, 2018, 39 : 1041 - 1047
  • [33] Embolic Stroke of Undetermined Source A Systematic Review and Clinical Update
    Hart, Robert G.
    Catanese, Luciana
    Perera, Kanjana S.
    Ntaios, George
    Connolly, Stuart J.
    STROKE, 2017, 48 (04) : 867 - 872
  • [34] Characteristics and prognosis of patients with embolic stroke of undetermined source in China
    Yang, Xiaomeng
    Jing, Jing
    Meng, Xia
    Li, Zixiao
    Pan, Yuesong
    Jiang, Yong
    Xiang, Xianglong
    Liu, Huan
    Chen, Yu
    Liu, Liping
    Zhao, Xingquan
    Wang, Yilong
    Li, Hao
    Wang, Yongjun
    INTERNATIONAL JOURNAL OF STROKE, 2022, 17 (05) : 526 - 535
  • [35] Rivaroxaban for Stroke Prevention after Embolic Stroke of Undetermined Source
    Hart, R. G.
    Sharma, M.
    Mundl, H.
    Kasner, S. E.
    Bangdiwala, S. I.
    Berkowitz, S. D.
    Swaminathan, B.
    Lavados, P.
    Wang, Y.
    Wang, Y.
    Davalos, A.
    Shamalov, N.
    Mikulik, R.
    Cunha, L.
    Lindgren, A.
    Arauz, A.
    Lang, W.
    Czlonkowska, A.
    Eckstein, J.
    Gagliardi, R. J.
    Amarenco, P.
    Ameriso, S. F.
    Tatlisumak, T.
    Veltkamp, R.
    Hankey, G. J.
    Toni, D.
    Bereczki, D.
    Uchiyama, S.
    Ntaios, G.
    Yoon, B. -W.
    Brouns, R.
    Endres, M.
    Muir, K. W.
    Bornstein, N.
    Ozturk, S.
    O'Donnell, M. J.
    Basson, M. M. De Vries
    Pare, G.
    Pater, C.
    Kirsch, B.
    Sheridan, P.
    Peters, G.
    Weitz, J. I.
    Peacock, W. F.
    Shoamanesh, A.
    Benavente, O. R.
    Joyner, C.
    Themeles, E.
    Connolly, S. J.
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (23) : 2191 - 2201
  • [36] Rivaroxaban for Stroke Prevention after Embolic Stroke of Undetermined Source
    Su, Qiang
    Li, Qinghua
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (10) : 986 - 986
  • [37] Embolic Stroke of Undetermined Source: Gateway to a New Stroke Entity?
    Schaebitz, Wolf-Ruediger
    Koehrmann, Martin
    Schellinger, Peter D.
    Minnerup, Jens
    Fisher, Marc
    AMERICAN JOURNAL OF MEDICINE, 2020, 133 (07) : 795 - 801
  • [38] Dabigatran for Prevention of Stroke after Embolic Stroke of Undetermined Source
    Diener, H. -C.
    Sacco, R. L.
    Easton, J. D.
    Granger, C. B.
    Bernstein, R. A.
    Uchiyama, S.
    Kreuzer, J.
    Cronin, L.
    Cotton, D.
    Grauer, C.
    Brueckmann, M.
    Chernyatina, M.
    Donnan, G.
    Ferro, J. M.
    Grand, M.
    Kallmuenzer, B.
    Krupinski, J.
    Lee, B. -C.
    Lemmens, R.
    Masjuan, J.
    Odinak, M.
    Saver, J. L.
    Schellinger, P. D.
    Toni, D.
    Toyoda, K.
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (20) : 1906 - 1917
  • [39] A tool to identify patients with embolic stroke of undetermined source at high recurrence risk
    Ntaios, George
    Georgiopoulos, Georgios
    Perlepe, Kalliopi
    Sirimarco, Gaia
    Strambo, Davide
    Eskandari, Ashraf
    Nannoni, Stefania
    Vemmou, Anastasia
    Koroboki, Eleni
    Manios, Efstathios
    Rodriguez-Campello, Ana
    Cuadrado-Godia, Elisa
    Roquer, Jaume
    Arnao, Valentina
    Caso, Valeria
    Paciaroni, Maurizio
    Diez-Tejedor, Exuperio
    Fuentes, Blanca
    Pardo, Jorge Rodriguez
    Sanchez-Velasco, Sara
    Arauz, Antonio
    Ameriso, Sebastian F.
    Pertierra, Lucia
    Gomez-Schneider, Maia
    Hawkes, Maximiliano A.
    Barboza, Miguel A.
    Cano, Beatriz Chavarria
    Mohedano, Ana Maria Iglesias
    Pastor, Andres Garcia
    Gil-Nunez, Antonio
    Putaala, Jukka
    Tatlisumak, Turgut
    Karagkiozi, Efstathia
    Papavasileiou, Vasileios
    Makaritsis, Konstantinos
    Bandini, Fabio
    Vemmos, Konstantinos
    Michel, Patrik
    NEUROLOGY, 2019, 93 (23) : E2094 - E2104
  • [40] Prevalence of Nonstenotic Carotid Plaque in Stroke Due to Atrial Fibrillation Compared to Embolic Stroke of Undetermined Source
    Siegler, James E.
    Thon, Jesse M.
    Woo, John H.
    Do, David
    Messe, Steven R.
    Cucchiara, Brett
    JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2019, 28 (10)